Phorbol 12,13-dibutyrate-induced protein kinase C activation triggers sustained contracture in human myometrium in vitro

Am J Obstet Gynecol. 2017 Sep;217(3):358.e1-358.e9. doi: 10.1016/j.ajog.2017.04.041. Epub 2017 May 4.

Abstract

Background: Although physiologic transition from rhythmic contractions to uterine retraction postpartum remains a poorly understood process, it has been shown that the latter is essential in the prevention of hemorrhage and its negative consequences.

Objective: To investigate the transition from oscillatory contractions to tonic contracture in human myometrium after delivery, a mechanism purported to facilitate postpartum hemostasis. Protein kinase C (PKC) plays a key regulatory role in human uterine contractions because it can prevent dephosphorylation of regulatory proteins and sensitize the contractile machinery to low Ca2+. Thus, activation of PKC by phorbol 12,13-dibutyrate (PDBu) may act as a strong uterotonic agent.

Study design: Uterine biopsies were obtained from consenting women undergoing elective caesarian delivery at term without labor (N = 19). Isometric tension measurements were performed on uterine strips (n = 114). The amplitudes and area under the curve of phasic contractions and tonic responses were measured and compared. A total of 1 μM PDBu was added to the isolated organ baths, and maximal tension of the uterine contracture was determined in the absence and presence of either 1 μM of staurosporine, 100 nM nifedipine, or 10 μM cyclopiazonic acid to assess the role of PKC and calcium sensitivity on uterine contractility.

Results: On the addition of PDBu on either basal or oxytocin-induced activity, consistent contractures were obtained concomitant with complete inhibition of phasic contractions. After a 30-minute incubation period, the mean amplitude of the PDBu-induced tone represented 65.3% of the amplitude of spontaneous contraction. Staurosporine, a protein kinase inhibitor, induced a 91.9% inhibition of PDBu contractures, a process not affected by nifedipine or cyclopiazonic acid, thus indicating that this mechanism is largely Ca2+ independent.

Conclusion: Pharmacologic activation of PKC leads to a significant contracture of the myometrium. Together, these data suggest that the up-regulation of PKC plays a physiologic role in the modulation of uterine contracture after delivery. A switch from phasic to strong tonic contractions potentially may facilitate postpartum hemostasis.

Keywords: PKC activator; PKC inhibitor; hemostasis; protein kinase C; uterine contractions.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Adult
  • Enzyme Inhibitors / pharmacology
  • Female
  • Humans
  • In Vitro Techniques
  • Indoles / pharmacology
  • Myometrium / drug effects*
  • Myometrium / metabolism
  • Nifedipine / pharmacology
  • Phorbol 12,13-Dibutyrate / pharmacology*
  • Protein Kinase C / drug effects*
  • Protein Kinase C / metabolism
  • Staurosporine / pharmacology
  • Tocolytic Agents / pharmacology
  • Uterine Contraction / drug effects*
  • Young Adult

Substances

  • Enzyme Inhibitors
  • Indoles
  • Tocolytic Agents
  • Phorbol 12,13-Dibutyrate
  • Protein Kinase C
  • Staurosporine
  • Nifedipine
  • cyclopiazonic acid